Page 32 - Sohini Das

Since Japan launch, Honda Elevate exports nearly double of India sales

Between April and June 2024 Honda exported 10,659 units of the Elevate meanwhile it sold 5,435 units of the Elevate in Indian market

Maharashtra, Tamil Nadu lead the race for Tesla's manufacturing unit

Gujarat also in list, if govt rolls out sops; in talks to rope in local partners

Steeling a march: Big Boys of steel pushing pedal to drive future mobility

From setting up cutting-edge facilities to cater to the domestic market and building capabilities of global standards, the action is building up

In future, we will have a few more listings from group: Ola Electric CEO

He believes this IPO is a key step in the company's long-term plan

Electric 2W player Ola Electric sets IPO price band at Rs 72-76 per share

Volume growth, vertical integration would be the main pillars for improving its margins, founder and CEO Bhavish Aggarwal told reporters on Monday

Tata Motors looks to drive into mid-SUV space with Curvv SUV Coupe

Curvv will be launched with the EV version, and within a month the ICE versions will come. EV customers also want a higher range

Bajaj Auto-powered electric mobility company Yulu eyes global ride

It plans to pedal overseas with a Bajaj product and accelerate into India's e-commerce space with a high-speed two-wheeler

BSV portfolio can touch Rs 5K cr in 3-4 yrs: Mankind Pharma's Rajeev Juneja

'We don't want to get into exports with generic or me-too products. We always wanted products with a high level of entry barriers and complexity'

Mankind Pharma to lead in Indian women's health market after BSV deal

Deal opens doors to overseas markets with low competition

In major boardroom reshuffle, Samina Hamied steps down from Cipla Board

The announcement comes amid reports that Cipla promoters are looking to sell their entire or partial shareholding in the company

Mankind Pharma acquires Bharat Serums and Vaccines for Rs 13,600 crore

More than 2,500 BSV employees will be joining Mankind

India may have dengue vaccine by 2026; Takeda initiates clinical trials

Takeda follows a dual pricing strategy in both private and public markets, and as such, prices in the private market are higher in Europe than in Asian markets

Health Budget focuses on strengthening state drug regulatory systems

In 2024-25, the Health Budget has allocated around Rs 75 crore for strengthening state drug regulatory systems, which is up from Rs 52 crore in the revised estimates of 2023-24

Rural India drives drop in poverty count over 6 years: Economic Survey

Survey says nearly 135 mn have emerged from multidimensional poverty

Healthcare has become more affordable and accessible: Eco Survey

As such, out-of-pocket expenditure (OOPE) as a percentage of THE has come down from 64.2 per cent in FY14 to 47.1 per cent in FY20

Nipah claims one life in Kerala; Maharashtra reports 28 Zika cases in 2024

Communicable disease scare grips people as Maharashtra reports 28 Zika cases this year

A ray of hope for Indian biz in Bangladesh after top court order

Bilateral trade at a standstill, operations of Indian companies halted due to the turmoil

Monsoon brings fever season to India; Kerala, Karnataka see Dengue spike

More than 10,000 cases of dengue, including eight fatal cases, have been reported so far this year in the adjacent state of Karnataka

US Biosecure Act spells long-term boost for Indian CDMO, CRO firms

As American biopharma looks to diversify sourcing, Indian companies stand to benefit

Bajaj Auto Q1 PAT up 18% at Rs 1,941.79 cr on double digit revenue growth

The revenue from operations grew due to strong vehicle sales, record revenue from spares, and volume expansion across both domestic and export businesses